Deutsche Märkte geschlossen

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
27,66+0,28 (+1,02%)
Börsenschluss: 05:35PM CEST

Fresenius SE & Co. KGaA

Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 6080
https://www.fresenius.com

Sektor(en)Healthcare
BrancheMedical Care Facilities
Vollzeitmitarbeiter193.865

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Michael SenCEO, President & Chairman of Management Board - Fresenius Management SE4,09MN/A1968
Ms. Sara Lisa HennickenCFO & Member of the Management Board - Fresenius Management SE1,55MN/A1980
Mr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius Kabi2MN/AN/A
Dr. Michael Sven Moser Ph.D.Member of Management Board of Fresenius Management SE1,2MN/A1978
Mr. Robert MollerMember of the Management Board of Fresenius Management SE1,15MN/A1971
Mr. Markus GeorgiSenior Vice President of Investor RelationsN/AN/AN/A
Matthias LinkSenior Vice President Corporate CommunicationsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Corporate Governance

Fresenius SE & Co. KGaAs ISS Governance QualityScore, Stand 1. April 2024, lautet 2. Die grundlegenden Scores sind Audit: 1, Vorstand: 3, Shareholderrechte: 1, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.